Navigation Links
Musculoskeletal Network Features New Research into the Cause of Rheumatoid Arthritis and Lupus

NORWALK, Conn., March 25, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network highlights growing evidence supporting the idea that many conditions related to arthritis are caused by cross-reactions between immune responses against infections and damage to the body's own tissues.

Diseases such as rheumatoid arthritis and lupus may be an indication of a defect in the body's ability to fight infection, rather than an over-reaction to it, writes rheumatologist Stephen Paget MD, physician-in-chief emeritus at the Hospital for Special Surgery in New York. Forthcoming research may confirm that, for many people with unexplainable conditions that cause joint pain and swelling, the unrecognized cause is infection, he predicts, pointing to a new focus for prevention and treatment.

Among the evidence behind his startling hypothesis, Dr. Paget points out that:

  • Rheumatoid arthritis has been strongly linked to periodontal disease, bacterial infection of the gums.
  • Some patients affected with Lyme disease, which is caused by a tick-borne bacterium, continue to have joint problems after all evidence of a living bacterium disappears.
  • The bacterium Chlamydia trachomatis, cause of a sexually transmitted disease (STD) that is often asymptomatic, can persist for years within joints, causing inflammation.

New research into the genomes of microorganisms, sponsored by a major government initiative, is revealing many infectious agents that were previously unknown, Dr. Paget points out, and more remain to be discovered.

About UBM Medica US

Addressing today's healthcare information needs, UBM Medica US delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include,,,,,, and UBM Medica US is part of UBM Connect—which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit

Media contact:

Jason J. Golden
Content Marketing Manager

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
2. Musculoskeletal Network Features Update on Nutraceuticals for Osteoarthritis
3. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
4. VIC Investor Network to Significantly Accelerate Technology Company Growth
5. Researchers create building block of quanutm networks
6. Secretary of Department of Environmental Protection, Michael Krancer, to Facilitate Networking Session at Pittcon 2013
7. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
8. Notre Dame to be part of $194 million university research center network
9. House to Vote on Post-Sandy Mold Relief Fund Next Week; Dr Mold Network Comments Amount is Truly Needed by Hurricane Victims
10. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
11. Possible Mold Infestation at Queens School Worries Parents; Doctor Mold Network Suggests a Mold Spray for a Safe and Effective Mold Remediation Process
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... June 22, 2016 Cell Applications, Inc. ... them to produce up to one billion human ... within one week. These high-quality, consistent stem cells ... cells and spend more time doing meaningful, relevant ... proprietary, high-volume manufacturing process that produces affordable, reliable ...
(Date:6/22/2016)... 2016  According to Kalorama Information, the dominant ... market include significant efforts in automation as well ... and affordable sequencers, say the healthcare market research ... including sample prep materials.  The healthcare market research ... for Next Generation Sequencing (NGS) , highlights major ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
Breaking Biology News(10 mins):